Literature DB >> 33281402

Robotic Surgery for Rectal Cancer: Hype or Hope? (Indian Experience).

S P Somashekhar1, K R Ashwin1, C Rohit Kumar1.   

Abstract

The primary goal to achieve cure in oncology is to reduce recurrence, maximize disease-free survival, maintain function, and optimize quality of life. Surgery remains the mainstay treatment modality in rectal cancer. The current trend is to perform least invasive method of doing complex surgeries while not compromising in the oncological of functional outcomes of patients. Total mesorectal excision (TME) for rectal cancer surgery entails removal of the rectum with its fascia as an intact unit while preserving surrounding vital structures. The procedure is technically challenging because of the narrow and deep pelvic cavity housing the rectum encased by fatty lymph vascular tissue within the perirectal fascia, distally the anal sphincter complex, and an intimate surrounded by vital structures like ureter, vessels, and nerves. Robotic technology enables overcoming these difficulties caused by complex pelvic anatomy. This system can facilitate better preservation of the pelvic autonomic nerve and thereby achieve favorable postoperative sexual and voiding functions after rectal cancer surgery. The nerve-preserving TME technique includes identification and preservation of the superior hypogastric plexus nerve, bilateral hypogastric nerves, pelvic plexus, and neurovascular bundles. © Indian Association of Surgical Oncology 2020.

Entities:  

Keywords:  Autonomic nerve preservation; Colorectal cancer; Robotics; Total mesorectal excision

Year:  2020        PMID: 33281402      PMCID: PMC7714808          DOI: 10.1007/s13193-020-01113-7

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  56 in total

1.  A comparison of surgeons' posture during laparoscopic and open surgical procedures.

Authors:  R Berguer; G T Rab; H Abu-Ghaida; A Alarcon; J Chung
Journal:  Surg Endosc       Date:  1997-02       Impact factor: 4.584

2.  Robotic versus laparoscopic total mesorectal excision for rectal cancer: a comparative analysis of oncological safety and short-term outcomes.

Authors:  P P Bianchi; C Ceriani; A Locatelli; G Spinoglio; M G Zampino; A Sonzogni; C Crosta; B Andreoni
Journal:  Surg Endosc       Date:  2010-06-05       Impact factor: 4.584

3.  Bladder and sexual function following resection for rectal cancer in a randomized clinical trial of laparoscopic versus open technique.

Authors:  D G Jayne; J M Brown; H Thorpe; J Walker; P Quirke; P J Guillou
Journal:  Br J Surg       Date:  2005-09       Impact factor: 6.939

4.  Oncologic outcomes of robotic-assisted total mesorectal excision for the treatment of rectal cancer.

Authors:  Jeong-Heum Baek; Shaun McKenzie; Julio Garcia-Aguilar; Alessio Pigazzi
Journal:  Ann Surg       Date:  2010-05       Impact factor: 12.969

5.  Prospective Randomized Study Comparing Robotic-Assisted Surgery with Traditional Laparotomy for Rectal Cancer-Indian Study.

Authors:  S P Somashekhar; K R Ashwin; Jaka Rajashekhar; Shabber Zaveri
Journal:  Indian J Surg       Date:  2013-11-11       Impact factor: 0.656

6.  Robotic Resection is a Good Prognostic Factor in Rectal Cancer Compared with Laparoscopic Resection: Long-term Survival Analysis Using Propensity Score Matching.

Authors:  Jin Kim; Se-Jin Baek; Dong-Woo Kang; Young-Eun Roh; Jae Won Lee; Han-Deok Kwak; Jung Myun Kwak; Seon-Hahn Kim
Journal:  Dis Colon Rectum       Date:  2017-03       Impact factor: 4.585

7.  Robot-assisted versus conventional laparoscopic surgery for colorectal disease, focusing on rectal cancer: a meta-analysis.

Authors:  Yongzhi Yang; Feng Wang; Peng Zhang; Chenzhang Shi; Yang Zou; Huanlong Qin; Yanlei Ma
Journal:  Ann Surg Oncol       Date:  2012-07-03       Impact factor: 5.344

8.  Multicentric study on robotic tumor-specific mesorectal excision for the treatment of rectal cancer.

Authors:  Alessio Pigazzi; Fabrizio Luca; Alberto Patriti; Manuela Valvo; Graziano Ceccarelli; Luciano Casciola; Roberto Biffi; Julio Garcia-Aguilar; Jeong-Heum Baek
Journal:  Ann Surg Oncol       Date:  2010-01-20       Impact factor: 5.344

9.  Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial.

Authors:  Martijn Hgm van der Pas; Eva Haglind; Miguel A Cuesta; Alois Fürst; Antonio M Lacy; Wim Cj Hop; Hendrik Jaap Bonjer
Journal:  Lancet Oncol       Date:  2013-02-06       Impact factor: 41.316

10.  Three-dimensional Versus Two-dimensional Laparoscopic Surgery for Colorectal Cancer: Systematic Review and Meta-analysis.

Authors:  George Pantalos; Dimitrios Patsouras; Eleftherios Spartalis; Dimitrios Dimitroulis; Gerasimos Tsourouflis; Nikolaos Nikiteas
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.